Abstract
Long‐term statins therapy is the primary treatments of hyperlipidemia. Ubiquinone (Co‐enzyme Q10, CoQ10) supplement ameliorates the statins side effects, including skeletal muscle and liver damage, whereas the mechanism involving respiratory chain complex function in hyperlipidemia animal model remains unknown. Here we report that the administration of CoQ10 increases plasma CoQ10 level significantly without affecting the lipid lowering effects of statins in high‐fat high cholesterol diet fed mice. Compared with statins group, the combination therapy of CoQ10 and statin (Simva + CoQ10) reduce the activity enhancement of plasma CK, ALT, and AST, and restore the activity of complex I in skeletal muscle (2.7fold increased) and liver (42% increased). Moreover, the activities of complex II are increased in muscle (29% increased) and liver (5.8 folds increased) significantly. Statins decrease the total CoQ10 concentration in mitochondria, while Simva + CoQ10 restore the total CoQ10 concentration in mitochondria from muscle (41% increased)and liver (1.1folds increased), respectively. Therefore, we conclude that the administration of CoQ10 ameliorates the function loss of mitochondria respiratory chain complex induced by statins in muscle and liver.
Practical Applications: Statins are widely used in clinical treatment of hypercholesterolemia and atherosclerotic diseases via inhibiting the synthesis of mevalonic acid to achieve the purpose of reducing endogenous cholesterol loading, to display anti‐inflammatory effects, and to stabilize the atherosclerotic plaques. However, the shortage of MVA may cause the low level of ubiquinone which subsequently led to increasing various side effects, including muscle and liver damage. This study introduces a novel combined administration which could ameliorate the statins induced muscle and liver damage for hypercholesterolemia individuals. Moreover, the method shows a beneficial effect on mitochondrion integrity and functions in skeletal muscle and liver.
http://bit.ly/2QIrZY8
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.